Inogen, Inc. (INGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:35PM EDT. Market open.
| Previous close | 6.48 |
| Open | 6.48 |
| Bid | 6.68 x 100 |
| Ask | 6.81 x 100 |
| Day's range | 6.47 - 6.75 |
| 52-week range | 4.13 - 14.10 |
| Volume | |
| Avg. volume | 537,429 |
| Market cap | 158.942M |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
GOLETA, Calif., April 10, 2024--Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
- Business Wire
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
GOLETA, Calif., March 25, 2024--Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
- Business Wire
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GOLETA, Calif., March 07, 2024--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were a
© 2024 Yahoo. All rights reserved.